Category: Endocrinology and Metabolism
Young, Bergamo Publish Studies On Continuous Glucose Monitoring in Elders and in Youth With Type 1 Diabetes
Laura Young, MD, PhD Laura Young, MD, PhD, and Katherine Bergamo, FNP-C, are local principal investigators for two papers recently published in the Journal of American Medicine Association. Young, associate professor in the division of endocrinology and metabolism, published the Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes. In this … Read more
Machineni Says Eating Meals Earlier in the Day Could Impact Weight Loss
Sriram Machineni, MD Sriram Machineni, MD, assistant professor of medicine in the division of endocrinology and metabolism was interviewed for a Pop Sugar article about weight loss and timing of meals. “A recent study may have confirmed just that when it showed that people who ate closer to the time when their bodies released melatonin 鈥� “at the onset of sleep,” said Machineni in … Read more
Transitioning Diabetes Patients To Virtual Care During Pandemic Shows Positive Results
Morgan Simonds Jones, MD In a journal article published in Diabetes Technology & Therapeutics, first author Morgan Jones, MD, assistant professor of medicine in the division of endocrinology and metabolism, said transitioning to virtual care models does not limit the glycemic outcomes of inpatient diabetes care. Telehealth visits for patients with diabetes appear to show posi … Read more
Young Shows Use of Continuous Glucose Monitoring Reduces Hypoglycemia in Older Adults with Type 1 Diabetes
Laura Young, MD Laura Young, MD, PhD, associate professor of medicine in the division of endocrinology and metabolism, was 黑料网’s principal investigator for a six-month clinical trial that shows the use of continuous glucose monitoring reduces serious levels of hypoglycemia compared with standard monitoring by daily use of blood glucose finger-stick test strips. Learn more from th … Read more
Buse, Site Leader For Effort Gathering Big Data to Accelerate COVID-19 fight
John Buse, MD, PhD A nationwide collaboration of clinicians, informaticians, and other biomedical researchers aims to turn data from hundreds of thousands of medical records from coronavirus patients into effective treatments and predictive analytical tools that could help lessen or end the global pandemic. Through the聽National COVID Cohort Collaborative, about 60 clinical instit … Read more
-
Jones Publishes Article Demonstrating Inpatient Transition to Virtual Care During COVID-19
Morgan Simonds Jones, MD Morgan S. Jones, MD, assistant professor of medicine in the division of endocrinology and metabolism, is lead author on a new paper published in Diabetes Technology and Therapeutics, reporting on novel approaches to the COVID-19 outbreak that leveraged 黑料网’s diabetes co-management service, initiated in July, 2019. Driven by the need to reduce the use of P … Read more
Buse Explains What People with Diabetes Need to Know About COVID-19聽
John Buse, MD, PhD John Buse, MD, PhD, chief of the division of endocrinology and metabolism, director of the 黑料网 Diabetes Care Center, and director of the North Carolina Translational and Clinical Sciences Institute, explains how diabetes is linked to more severe cases of COVID-19 in a new 黑料网 Health article. He also encourages patients not to skip their diabetes-related visits … Read more
-
Buse Discusses the Future of Insulin
John Buse, MD, PhD John Buse, MD, MPH, was interviewed by Endocrine Today describing what the future of insulin may look like. The article recognizes novelty treatments to manage diabetes, including the smart insulin patch that “leverages chemistry to release insulin in parallel with fluctuations of glucose.鈥� Buse says that if “successfully translated to human use, it could drama … Read more
Kirkman Talks to Livestrong.com About Prediabetes
Sue Kirkman, MD Sue Kirkman, MD,聽talked to聽Livestrong.com about prediabetes and what most people should know about the condition. The article explains prediabetes as a condition that occurs when blood sugar levels are high, but not high enough to be considered type 2 diabetes. “It’s sort of an in-between condition,” says Kirkman in the article. “It’s considered a precursor to typ … Read more
-
Buse Talks To Livestrong.com About Type 2 Diabetes and Who Is At Risk
John Buse, MD, PhD John Buse, MD, MPH, talked to Livestrong.com about the key things to know about type 2 diabetes. “Insulin functions as the key that unlocks the door that allows sugar to go from the bloodstream into the cells and tissues to be used as fuel,” explains Buse in the article. He also recognizes “Type 1 is more often (though not exclusively) diagnosed in children, te … Read more
Department of Medicine Grants & Funding: April 1-April 30, 2020
Division of Endocrinology and Metabolism John Buse, MD, PhD, is 黑料网 site principal investigator for a $5.7 million diabetes聽research collaboration聽with Duke, Wake Forest, and NC A&T, funded through the National Institutes of Health. Janet Rubin, MD, received a $2.4 million聽grant聽from the NIH NIAMSD to study the role of force regulated nuclear structure in expression of osteog … Read more
Rubin Receives $2.4M Grant From National Institute of Arthritis and Musculoskeletal and Skin Diseases
Janet Rubin, MD Janet Rubin, MD, the Sarah Graham Kenan Distinguished Professor of Medicine in the division of endocrinology and metabolism, has received a five-year R01 grant from the NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases. The $2.4 million grant will support a study of the role of force regulated nuclear structure in expression of osteogenes … Read more